000			01937 a2200529 4500
005			20250515005001.0
264		0	_c20060915
008			200609s 0 0 eng d
022			_a0022-5347
024	7		_a10.1097/01.ju.0000181810.22617.f8 _2doi
040			_aNLM _beng _cNLM
100	1		_aAl-Tourah, Abdulwahab J
245	0	0	_aMinimizing treatment without compromising cure with primary surveillance for clinical stage I embryonal predominant nonseminomatous testicular cancer: a population based analysis from British Columbia. _h[electronic resource]
260			_bThe Journal of urology _cDec 2005
300			_a2209-13, discussion 2213 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAntineoplastic Agents _xtherapeutic use
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aBritish Columbia
650	0	4	_aCarcinoma, Embryonal _xdrug therapy
650	0	4	_aChemotherapy, Adjuvant
650	0	4	_aFollow-Up Studies
650	0	4	_aHumans
650	0	4	_aLymph Node Excision
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasm Invasiveness
650	0	4	_aNeoplasm Recurrence, Local _xtherapy
650	0	4	_aNeoplasm Staging
650	0	4	_aOrchiectomy
650	0	4	_aPopulation Surveillance
650	0	4	_aRetroperitoneal Space
650	0	4	_aRetrospective Studies
650	0	4	_aRisk Factors
650	0	4	_aSurvival Analysis
650	0	4	_aTesticular Neoplasms _xdrug therapy
650	0	4	_aTreatment Outcome
700	1		_aMurray, Nevin
700	1		_aCoppin, Chris
700	1		_aKollmannsberger, Christian
700	1		_aMan, Ada
700	1		_aChi, Kim N
773	0		_tThe Journal of urology _gvol. 174 _gno. 6 _gp. 2209-13, discussion 2213
856	4	0	_uhttps://doi.org/10.1097/01.ju.0000181810.22617.f8 _zAvailable from publisher's website
999			_c15905575 _d15905575